Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

Oncogene

Volumn 30, Issue 11, 2011, Pages 1351-1359

  Park, S Y ^a   Jeong, K J ^a   Panupinthu, N ^b   Yu, S ^b   Lee, J ^b   Han, J W ^c   Kim, J M ^d   Lee, J S ^b   Kang, J ^a   Park, C G ^a   Mills, G B ^b   Lee, H Y ^a  

^a Konyang University   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Sungkyunkwan University   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

human hepatocellular carcinoma cells; invasion; LPA1; lysophosphatidic acid; matrix metalloproteinase 9

Indexed keywords

AUTOTAXIN; BIOLOGICAL MARKER; GELATINASE B; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOMA CELL; FETUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 79952745018     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.517     Document Type: Article

References (34)

1. Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M et al. (1996). Overexpression of matrix metalloproteinase 9 gene in hepato-cellular carcinoma with invasive potential. Hepatology 24: 316-322. (Pubitemid 26260026)
2. Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clezardin P, Peyruchaud O. (2006). The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc Natl Acad Sci USA 103: 9643-9648. (Pubitemid 43955878)
3. Brinkmann V. (2007). Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 115: 84-105. (Pubitemid 46990553)
4. Byun HS, Won M, Park KA, Kim YR, Choi BL, Lee H et al. (2008). Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase. Exp Mol Med 40: 186-195. (Pubitemid 351738724)
5. Chung TW, Lee YC, Kim CH. (2004). Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. Faseb J 18: 1123-1125.
6. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R et al. (2004). Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279: 17634-17639. (Pubitemid 38560528)
7. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y et al. (1996). Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 24: 1058-1062. (Pubitemid 26365903)
8. Hidalgo M, Eckhardt SG. (2001). Development of matrix metalloprotei-nase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193. (Pubitemid 32166488)
9. Jiang YF, Yang ZH, Hu JQ. (2000). Recurrence or metastasis of HCC: predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 6: 61-65. (Pubitemid 30093064)
10. Kim JH, Na HK, Pak YK, Lee YS, Lee SJ, Moon A et al. (2008). Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells. Chem Biol Interact 171: 133-141.
11. Lee J, Park SY, Lee EK, Park CG, Chung HC, Rha SY et al. (2006a). Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res 12: 6351-6358. (Pubitemid 44799704)
12. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF et al. (2006b). A novel prognostic subtype of human ddddddddddddddhepato-cellular carcinoma derived from hepatic progenitor cells. Nat Med 12: 410-416.
13. Liu JF, Crepin M, Liu JM, Barritault D, Ledoux D. (2002). FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293: 1174-1182. (Pubitemid 34681065)
14. Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F et al. (2009). Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 15: 539-550.
15. McKenna GJ, Chen Y, Smith RM, Meneghetti A, Ong C, McMaster R et al. (2002). A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg 183: 588-594. (Pubitemid 34603436)
16. Mills GB, Moolenaar WH. (2003). The emerging role of lysophos-phatidic acid in cancer. Nat Rev Cancer 3: 582-591. (Pubitemid 37328830)
17. Murph MM, Nguyen GH, Radhakrishna H, Mills GB. (2008). Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation. Biochim Biophys Acta 1781: 547-557.
18. Murph MM, Scaccia LA, Volpicelli LA, Radhakrishna H. (2003). Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway. J Cell Sci 116: 1969-1980. (Pubitemid 36622295)
19. Noguchi K, Herr D, Mutoh T, Chun J. (2009). Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9: 15-23.
20. Parkin DM, Bray F, Ferlay J, Pisani P. (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156. (Pubitemid 32911406)
21. Ren J, Xiao YJ, Singh LS, Zhao X, Zhao Z, Feng L et al. (2006). Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 66: 3006-3014.
22. Sengupta S, Xiao YJ, Xu Y. (2003). A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells. Faseb J 17: 1570-1572.
23. Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ et al. (2008). Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 18: 1606-1612.
24. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T et al. (2003). Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63: 1706-1711. (Pubitemid 36373664)
25. Simon C, Goepfert H, Boyd D. (1998). Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92 000 type IV collagenase secretion and in vitro invasion. Cancer Res 58: 1135-1139. (Pubitemid 28183199)
26. Skill NJ, Scott RE, Wu J, Maluccio MA. (2009). Hepatocellular carcinoma associated lipid metabolism reprogramming. J Surg Res (in press).
27. Wang DS, Dou KF, Li KZ, Song ZS. (2004). Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway. World J Gastroenterol 10: 299-302.
28. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS et al. (2004). Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853. (Pubitemid 38445410)
29. Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M et al. (2010). Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer 9: 71.
30. Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T et al. (2004). Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J Biol Chem 279: 6595-6605. (Pubitemid 38248796)
31. Yu S, Murph MM, Lu Y, Liu S, Hall HS, Liu J et al. (2008). Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 100: 1630-1642.
32. Zhang G, Zhao Z, Xu S, Ni L, Wang X. (1999). Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin Med J (Engl) 112: 330-332.
33. Zhao Z, Xu S, Zhang G. (1999). [A study on expression of autotaxin mRNA in hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 7: 140-141.
34. Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC. (1999). Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29: 1208-1214. (Pubitemid 29168756)